Tocilizumab and COVID-19: Timing of Administration and Efficacy

• मुख्य लेखकों: Emna Abidi (लेखक), Wasim S. El Nekidy (लेखक), Eman Alefishat (लेखक), Nadeem Rahman (लेखक), Georg A. Petroianu (लेखक), Rania El-Lababidi (लेखक), Jihad Mallat (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Frontiers Media S.A., 2022-02-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Elevated concentrations of interleukin-6 have been demonstrated to be an important key factor in COVID-19 host immune impairment. It represents an important prognostic factor of harm associated with COVID-19 infection by stimulating a vigorous proinflammatory response, leading to the so-called "...